tiprankstipranks
Bioxytran Inc (BIXT)
OTHER OTC:BIXT
US Market

Bioxytran (BIXT) Financial Statements

14 Followers

Bioxytran Financial Overview

Bioxytran's market cap is currently ―. The company's EPS TTM is $-0.031; its P/E ratio is -3.18; Bioxytran is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Sep 23Jun 23Mar 23Dec 22Sep 22
Income Statement-
Total Revenue----$ 0.00
Gross Profit-----
EBIT$ -987.27K$ -1.37M$ -885.20K$ -1.12M$ 13.31K
EBITDA$ -985.46K$ -1.02M$ -884.68K$ -900.36K$ 14.22K
Net Income Common Stockholders$ -1.00M$ -1.41M$ 850.87K$ -805.67K$ -123.15K
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 80.27K$ 45.18K$ 153.80K$ 295.40K$ 374.19K
Total Assets$ 189.04K$ 143.06K$ 233.53K$ 370.94K$ 448.54K
Total Debt$ 1.90M$ 2.00M$ 2.17M$ 2.17M$ 2.16M
Net Debt$ 1.82M$ 1.95M$ 2.01M$ 1.87M$ 1.78M
Total Liabilities$ 2.33M$ 2.77M$ 4.29M$ 3.66M$ 3.00M
Stockholders Equity$ -1.48M$ -2.00M$ -3.44M$ -2.70M$ -2.01M
Cash Flow-
Free Cash Flow$ -355.27K$ -173.62K$ -191.60K$ -158.79K$ -726.49K
Operating Cash Flow$ -342.58K$ -153.28K$ -186.89K$ -156.69K$ -718.77K
Investing Cash Flow$ -12.69K$ -20.34K$ -4.71K$ -2.10K$ -7.71K
Financing Cash Flow$ 390.36K$ 65.00K$ 50.00K$ 80.00K$ 600.00K
Currency in USD

Bioxytran Earnings and Revenue History

Bioxytran Debt to Assets

Bioxytran Cash Flow

Bioxytran Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis